Literature DB >> 34085362

The role of psychosocial factors in Black women's self-efficacy in receiving genetic counseling and testing.

Huanghe Ding1, Arnethea L Sutton2, Alejandra Hurtado-de-Mendoza3, Vanessa B Sheppard2,4.   

Abstract

Higher self-efficacy in receiving genetic counseling and testing (GCT) has been associated with greater participation in GCT for women at risk of hereditary breast and ovarian cancer (HBOC), but little is known about correlates of self-efficacy in Black women eligible for GCT. The goal of this secondary analysis was to identify sociodemographic and psychosocial factors regarding GCT. Multivariable regression analysis was conducted to assess the relationship between self-efficacy and correlates of interest. Of the 100 Black women surveyed, most women had a college degree (64%), were employed (84%), and had health insurance (93%). In the multivariable model, greater self-efficacy was associated with more positive attitudes toward GCT (Β = 0.126; CI = 0.01 to 0.25; p = 0.039), greater confidence in the Genetic Information Nondiscrimination Act (GINA) (Β = 0.250; CI = 0.04 to 0.46; p = 0.019), and lower ratings of perceived difficulty obtaining GCT (Β = -0.219; CI = -0.46 to -0.10; p = 0.003). Community-level interventions to promote self-efficacy are needed that address perceived barriers to GCT, with the goals of increasing GINA Law awareness in the general public, increasing accessibility to genetic counseling (e.g., telemedicine), and promoting more positive attitudes about GCT.
© 2021 National Society of Genetic Counselors.

Entities:  

Keywords:  disparities; genetic counseling; psychosocial; underrepresented populations

Mesh:

Year:  2021        PMID: 34085362     DOI: 10.1002/jgc4.1439

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  1 in total

1.  Population screening to identify women at risk for hereditary breast cancer syndromes: The path forward or the road not taken?

Authors:  Vida Henderson; Pam Ganschow; Catharine Wang; Kent F Hoskins
Journal:  Cancer       Date:  2021-08-23       Impact factor: 6.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.